• PEAK Matrix®
    July 09, 2026

    Enterprises are rethinking recruitment strategies as hiring demand stabilizes following a prolonged market slowdown, while continuing to navigate economic uncertainty, budget pressures, and persistent skill shortages. Organizations are increasingly seeking flexible recruitment models that can scale…
  • Viewpoint
    July 07, 2026

    AI is no longer simply changing how talent decisions are made; it is reshaping how organizations define talent, structure work, and build workforce advantage. As enterprises accelerate AI adoption, the focus is expanding beyond process transformation…
  • Viewpoint
    June 23, 2026

    Artificial intelligence (AI) is rapidly becoming a core component of Talent Acquisition (TA) and HR strategy as organizations navigate evolving skill requirements, rising application volumes, and increasing pressure to deliver measurable business outcomes. While AI adoption…
  • LinkedIn Live
    Nov. 19, 2025

    In an evolving landscape where analyst relations (AR) shape market perception and business success, leaders continued to look for proven tactics embraced by experienced AR professionals. Everest Group’s Katrina Menzigian, along with industry experts from other…
  • Thematic Report
    June 20, 2024

    Patient recruitment is a complex and dynamic part of clinical trial management, requiring proactive strategies, collaborations, and innovation to overcome challenges and achieve enrollment targets. Patient recruitment is vital for clinical trials, yet it presents challenges…
  • PEAK Matrix®
    June 03, 2024

    The evolving regulatory landscape poses significant challenges for life sciences enterprises. Enterprises struggle to navigate complex compliance frameworks, stay updated with emerging regulations, and manage diverse geographical requirements, all vital for achieving regulatory compliance and securing…
  • Viewpoint
    May 31, 2024

    Healthcare organizations use Revenue Cycle Management (RCM) to manage the administrative and clinical functions related to processing claims, receiving payments, and generating revenue. The cycle begins with a patient scheduling an appointment and continues until the…
  • Provider Compendium
    Feb. 08, 2024

    Over the past year, enterprises have faced significant macroeconomic and geopolitical challenges. The potential uncertainties surrounding the implementation of the Inflation Reduction Act (IRA), the escalation in federal interest rates aimed at curbing inflation, and the…
  • PEAK Matrix®
    Sep. 28, 2023

    Over the past one year, enterprises had to overcome a series of macroeconomic and geopolitical challenges. The potential uncertainties with the implementation of the Inflation Regulation Act (IRA), and the rise in federal interest rates to…
  • Provider Compendium
    June 30, 2023

    Everest Group’s Life Sciences Sales and Marketing Operations – Service Provider Compendium 2023 provides comprehensive and fact-based snapshots of 17 life sciences sales and marketing service providers. It offers a detailed profile of each provider, with…
  • Thematic Report
    April 06, 2023

    The life sciences industry has always been resilient against global macroeconomic, geopolitical, and regulatory changes. With the onset of COVID-19 and the spiraling demand for vaccines, the clinical trials and R&D spend of top biopharmas have…
  • PEAK Matrix®
    March 29, 2023

    The life sciences industry is currently facing several challenges that are significantly impacting drug and device manufacturing costs. In addition to these rising costs, regulatory developments such as the Inflation Reduction Act 2023 and upcoming patent…
  • Viewpoint
    Feb. 23, 2023

    Labeling and artwork are vital components of the life sciences industry, as they ensure regulatory compliance and can be used in packaging, online, and in the supply chain. Failure to comply with Good Manufacturing Practice (GMP)…
  • Nov. 30, 2022

    In this video, Ankur Verma, Practice Director, and Gokul Janardhan, Senior Analyst, discuss the pharmacovigilance industry and how it’s become a significant market in terms of spend from life science enterprises, currently a US$19 billion market.…
  • Oct. 31, 2022

    Improved supply chain visibility can help global pharmaceutical and medical device suppliers overcome the many logistics challenges they face post-pandemic. Internet of things (IoT) and blockchain technologies offer promise to address the growing demand for product…
  • Oct. 31, 2022

    Supply chain visibility, strategic sourcing, cold chain requirements, sustainability demands, and personalized medicine are creating opportunities in the life sciences supply chain for IT partners delivering digital solutions. Read this first part of our blog series…
  • Viewpoint
    Sep. 30, 2022

    The rising burden of chronic diseases worldwide is driving life sciences companies’ drug development efforts. These drug development efforts need to abide by the strict drug safety regulations of public health organizations, such as the US…
  • Provider Compendium
    Sep. 20, 2022

    Life Sciences (LS) Operations – Service Provider Compendium provides accurate, comprehensive, and fact-based snapshots of 31 providers, including their scale of operations, technology solutions, and delivery locations, along with Everest Group’s PEAK Matrix® provider assessment. The…
  • Provider Compendium
    Sep. 16, 2022

    With the increasing adoption of remote monitoring technologies, wearables, and smart implants following the pandemic, the medical devices industry is shifting toward building a connected care ecosystem that seamlessly integrates people, technology, and data across the…
  • PEAK Matrix®
    Aug. 04, 2022

    With the increasing adoption of remote monitoring technologies, wearables, and smart implants following the pandemic, the medical devices industry is shifting toward building a connected care ecosystem that seamlessly integrates people, technology, and data across the…

Items per page